Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
NeuBase Therapeutics (NBSE) Terminates CEO Dietrich A. Stephan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NeuBase Therapeutics (NASDAQ:NBSE – Get Rating) and Pyxis Oncology (NASDAQ:PYXS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability. Insider and Institutional Ownership 37.2% of NeuBase Therapeutics shares […]
16.05.2023 - Appointed Jeffrey Kindler, J.D. and John Maraganore, Ph.D. as strategy and business advisors to the CompanyPITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) - NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company . Seite 1